Identifying patients with cocaine-related chest pain at true risk for β-blocker toxicity

Archives of Internal Medicine

Volumn 170, Issue 20, 2010, Pages 1859-

  Canning, Joshua ^a   Brooks, Daniel E ^a   Gerkin, Richard D ^a  

^a Banner University Medical Center Phoenix   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARVEDILOL; COCAINE; METHAMPHETAMINE;

DELIRIUM; DRUG SAFETY; HUMAN; HYPERTENSION; HYPERTHERMIA; NEUROMUSCULAR DISEASE; NOTE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TACHYCARDIA; THORAX PAIN; VITAL SIGN;

ADRENERGIC BETA-ANTAGONISTS; CHEST PAIN; COCAINE; COCAINE-RELATED DISORDERS; DRUG SYNERGISM; ELECTROCARDIOGRAPHY; HUMANS;

EID: 78149372204     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.397     Document Type: Note

References (4)

1. Rangel C, Shu RG, Lazar LD, Vittinghoff E, Hsue PY, Marcus GM. β-Blockers for chest pain associated with recent cocaine use. Arch Intern Med. 2010;170(10):874-879.
2. Williams JB, Keenan SM, Gan Q, Knuepfer MM. Hemodynamic response profile predicts susceptibility to cocaine-induced toxicity. Eur J Pharmacol. 2003;464(2-3):189-196.
3. Fareed FN, Chan GM, Hoffman RS. Death temporally related to the use of a Beta adrenergic receptor antagonist in cocaine associated myocardial infarction. J Med Toxicol. 2007;3(4):169-172.
4. Damodaran S. Cocaine and beta-blockers: the paradigm. Eur J Intern Med. 2010;21(2):84-86.